A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154

NCT04972968 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

181

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic considerations

Conditions

Polymyalgia Rheumatica

Interventions

DRUG: ABBV-154
DRUG: Placebo
DRUG: Glucocorticoid

Sponsor

AbbVie